Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects-Reference-Cited by-同舟云学术

Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects

Published:2004-04 Issue:4 Volume:5 Page:375-387
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Tuveson David A,Shaw Alice T,Willis Nicholas A,Silver Daniel P,Jackson Erica L,Chang Sandy,Mercer Kim L,Grochow Rebecca,Hock Hanno,Crowley Denise,Hingorani Sunil R,Zaks Tal,King Catrina,Jacobetz Michael A,Wang Lifu,Bronson Roderick T,Orkin Stuart H,DePinho Ronald A,Jacks Tyler

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference47 articles.

1. The ras gene family and human carcinogenesis;Bos;Mutat. Res.,1988

2. ras oncogenes in human cancer;Bos;Cancer Res.,1989

3. Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder;Braun;Proc. Natl. Acad. Sci. USA,2004

4. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease;Chan;J. Clin. Invest.,2004

5. E1A signaling to p53 involves the p19(ARF) tumor suppressor;de Stanchina;Genes Dev.,1998

Cited by 684 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a new flippase-dependent mouse model for red fluorescence-based isolation of Kras^G12Doncogene-expressing tumor cells;2024-07-26

2. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice;Nature Communications;2024-07-22

3. KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways;Cells;2024-07-19

4. Large-Scale Genome-Wide Optimization and Prediction of the Cre Recombinase System for Precise Genome Manipulation in Mice;2024-07-03

5. Мутации в генах KRAS/NRAS и эффективность индукционной терапии по трехкомпонентным схемам на основе бортезомиба у пациентов с впервые диагностированной множественной миеломой;Clinical Oncohematology;2024-07-01